Treatment of relapsing mild-to-moderate ulcerative colitis with the probiotic VSL# 3 as adjunctive to a standard pharmaceutical treatment: a double-blind, randomized …

…, G Brandimarte, A Papa, A Giglio, W Elisei… - Official journal of the …, 2010 - journals.lww.com
OBJECTIVES: VSL# 3 is a high-potency probiotic mixture that has been used successfully
in the treatment of pouchitis. The primary end point of the study was to assess the effects of …

Faecal calprotectin in colonic diverticular disease: a case–control study

A Tursi, G Brandimarte, W Elisei, GM Giorgetti… - International journal of …, 2009 - Springer
Background and aims Information about faecal calprotectin (FC) in colonic diverticular
disease (DD) are lacking. We assessed FC in colonic DD, comparing it with irritable bowel …

Mesalazine and/or Lactobacillus casei in preventing recurrence of symptomatic uncomplicated diverticular disease of the colon: a prospective, randomized, open …

…, G Brandimarte, GM Giorgetti, W Elisei - Journal of clinical …, 2006 - journals.lww.com
Background Both mesalazine and probiotics showed recently their effectiveness in obtaining
remission of symptomatic uncomplicated diverticular disease of the colon. Consistent data …

[HTML][HTML] Interactions between innate immunity, microbiota, and probiotics

…, P Flamini, G Sandri, MC Trotta, W Elisei… - Journal of immunology …, 2015 - hindawi.com
The term “microbiota” means genetic inheritance associated with microbiota, which is about
100 times larger than the guest. The tolerance of the resident bacterial flora is an important …

Assessment and grading of mucosal inflammation in colonic diverticular disease

A Tursi, G Brandimarte, W Elisei… - Journal of clinical …, 2008 - journals.lww.com
Background Mucosal inflammation in colonic DD has never been investigated. In particular,
it is unknown whether inflammation may be found in every degree of DD. Materials and …

Assessment of fecal microbiota and fecal metabolome in symptomatic uncomplicated diverticular disease of the colon

…, P Mastromarino, D Capobianco, W Elisei… - Journal of clinical …, 2016 - journals.lww.com
Background: Whether intestinal microbiota and metabolic profiling may be altered in patients
with SUDD is unknown. Patients and Methods: Stool samples from 44 consecutive women […

Stepwise training in rectal and colonic endoscopic submucosal dissection with differentiated learning curves

…, G Costamagna, T Gotoda, Y Saito, W Elisei… - Gastrointestinal …, 2012 - Elsevier
BACKGROUND: Endoscopic submucosal dissection (ESD) has revolutionized the resection
of GI superficial neoplasms, but adoption in Western countries is significantly delayed. …

High prevalence of celiac disease among patients affected by Crohn's disease

…, GM Giorgetti, G Brandimarte, W Elisei - Inflammatory bowel …, 2005 - academic.oup.com
Background Recent literature has shown a correlation between Crohn's disease (CD) and
celiac disease, but a prospective study has not been performed. Our aim was to evaluate the …

Balsalazide and/or high-potency probiotic mixture (VSL# 3) in maintaining remission after attack of acute, uncomplicated diverticulitis of the colon

A Tursi, G Brandimarte, GM Giorgetti, W Elisei… - International journal of …, 2007 - Springer
Background and aims The role of probiotics in the treatment of diverticulitis is still not known.
The aim of our study was to investigate whether balsalazide and/or VSL#3 is effective in …

Impaired human gallbladder lipid absorption in cholesterol gallstone disease and its effect on cholesterol solubility in bile

SG Corradini, W Elisei, L Giovannelli, C Ripani… - Gastroenterology, 2000 - Elsevier
Background & Aims: The role of the gallbladder in gallstone pathogenesis is still unclear.
We examined the effects of gallbladder mucosal lipid absorption on lipid composition and …